Inhibition of erythrocyte sickling in vitro by pyridoxal.

J A Kark; M P Kale; P G Tarassoff; M Woods; L S Lessin

doi:10.1172/JCI109202

Find articles by Kark, J. in: PubMed | Google Scholar

Find articles by Kale, M. in: PubMed | Google Scholar

Find articles by Tarassoff, P. in: PubMed | Google Scholar

Find articles by Woods, M. in: PubMed | Google Scholar

Find articles by Lessin, L. in: PubMed | Google Scholar

Published in Volume 62, Issue 4 on October 1, 1978
J Clin Invest. 1978;62(4):888–891. https://doi.org/10.1172/JCI109202.
© 1978 The American Society for Clinical Investigation

Published October 1, 1978 - Version history

To test the antisickling activity of pyridoxal, we compared the oxygen affinity and the percent sickling at low PO2 of untreated erythrocytes with values for cells from the same blood sample incubated with pyridoxal, glyceraldehyde, or pyridoxine. Pyridoxal increased oxygen affinity much more than glyceraldehyde. 20 mM pyridoxal and glyceraldehyde had equivalent antisickling activity. At PO2 levels above 20 mm Hg, both agents reduced sickling to less than 2%. In samples examined by electron microscopy, pyridoxal reduced the percent sickled cells and the percent cells that contain hemoglobin S fibers by the same amount (from 74 to 3%). Pyridoxine had no effect on oxygen affinity or sockling. Pyridoxal reacts with intracellular hemoglobin to increase oxygen affinity, which inhibits hemoglobin S polymerization and sickling.

Images.

Click on an image below to see the page. View PDF of the complete article